Endocrinology, Vol 108, 193-198, Copyright © 1981 by Endocrine Society

ARTICLES

The effect of prostaglandins on the release of arginine vasopressin from the guinea pig hypothalamo-neurohypophyseal complex in organ culture

S Ishikawa, T Saito and S Yoshida

The effect of prostaglandins (PGs) on arginine vasopressin (AVP) release was investigated using the male guinea pig hypothalamo- neurohypophyseal complex (HNC) in organ culture. The explants of HNC were used on the second day in culture. The culture medium containing PGE2 caused an increase in AVP release from the explants during a 10- min incubation period. AVP release was significantly increased at a PGE2 concentration of 2 X 10(-8) M or more. AVP release was increased in a dose-dependent manner. PGF2 alpha at concentrations of 1.4 X 10(- 7) and 1.4 X 10(-6) M also increased AVP release significantly. The explants in the group treated with 7.4 X 10(-5) M indomethacin for 60 min before the experiment and throughout the experiment responded to 6.5 X 10(-8) M angiotensin II with a 166 +/- 42% increase in AVP release over control release. The response of explants to the addition of angiotensin II in this group was significantly lower (P less than 0.05) than that in the group not treated with indomethacin, which was 439 +/- 128% of the basal value (P less than 0.05). The release of AVP in the group treated with indomethacin was 120 +/- 15% of the basal value in response to a hypertonic solution of sodium chloride at 310 mosmol/kg H2O and was significantly lower (P less than 0.05) than that in the group not treated with indomethacin (203 +/- 30% of the basal value; P less than 0.005). However, indomethacin did not alter basic release of AVP. These results suggest that PGE2 and PGF2 alpha increase AVP release from the explants of HNC in organ culture, although PGF 2 alpha has a relatively weaker effect than PGE2, and PGs may modulate the regulation of AVP release in response to angiotensin II and osmotic stimulation.

This article has been cited by other articles:

				C. R. J. Kennedy, H. Xiong, S. Rahal, J. Vanderluit, R. S. Slack, Y. Zhang, Y. Guan, M. D. Breyer, and R. L. Hebert Urine concentrating defect in prostaglandin EP1-deficient mice Am J Physiol Renal Physiol, February 1, 2007; 292(2): F868 - F875. [Abstract] [Full Text] [PDF]

				C. Kitiyakara, W. J. Welch, J. G. Verbalis, and C. S. Wilcox Role of thromboxane receptors in the dipsogenic response to central angiotensin II Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R865 - R869. [Abstract] [Full Text] [PDF]

				C. S. Wilcox, H. Gao, J. G. Verbalis, and W. J. Welch Role of AVP in pressor responses during activation of central TxA2/PGH2 receptors Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1927 - H1932. [Abstract] [Full Text] [PDF]

				S. Jenab and P. L. Morris Transcriptional Regulation of Sertoli Cell Immediate Early Genes by Interleukin-6 and Interferon-{gamma} Is Mediated through Phosphorylation of STAT-3 and STAT-1 Proteins Endocrinology, July 1, 1997; 138(7): 2740 - 2746. [Abstract] [Full Text] [PDF]

				H. Takechi, K. Matsumura, Y. Watanabe, K. Kato, R. Noyori, M. Suzuki, and Y. Watanabe A Novel Subtype of the Prostacyclin Receptor Expressed in the Central Nervous System J. Biol. Chem., March 8, 1996; 271(10): 5901 - 5906. [Abstract] [Full Text] [PDF]